KILSTRUP-NIELSEN, CHARLOTTE
 Distribuzione geografica
Continente #
NA - Nord America 6.628
EU - Europa 3.605
AS - Asia 2.445
SA - Sud America 235
Continente sconosciuto - Info sul continente non disponibili 70
AF - Africa 52
OC - Oceania 26
AN - Antartide 1
Totale 13.062
Nazione #
US - Stati Uniti d'America 6.493
IT - Italia 1.770
SG - Singapore 817
CN - Cina 574
UA - Ucraina 526
VN - Vietnam 357
DE - Germania 252
HK - Hong Kong 251
TR - Turchia 247
SE - Svezia 227
BR - Brasile 194
FI - Finlandia 182
IE - Irlanda 152
GB - Regno Unito 146
FR - Francia 133
RU - Federazione Russa 82
CA - Canada 62
IN - India 43
JP - Giappone 43
BD - Bangladesh 38
MX - Messico 29
AU - Australia 26
NL - Olanda 26
GH - Ghana 21
BE - Belgio 20
PL - Polonia 20
ES - Italia 19
AR - Argentina 16
AT - Austria 12
CR - Costa Rica 12
IR - Iran 12
ZA - Sudafrica 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
GT - Guatemala 7
UZ - Uzbekistan 7
HN - Honduras 6
IL - Israele 6
PH - Filippine 6
CL - Cile 5
CO - Colombia 5
EC - Ecuador 5
ID - Indonesia 5
MA - Marocco 5
PT - Portogallo 5
DK - Danimarca 4
EG - Egitto 4
JM - Giamaica 4
MY - Malesia 4
PR - Porto Rico 4
TN - Tunisia 4
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
JO - Giordania 3
KR - Corea 3
MD - Moldavia 3
NG - Nigeria 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
GY - Guiana 2
KE - Kenya 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
AQ - Antartide 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 12.998
Città #
Milan 1.094
San Jose 510
Ashburn 488
Fairfield 473
Singapore 449
Chandler 431
Jacksonville 404
Woodbridge 358
Houston 340
Hong Kong 245
Ann Arbor 243
Council Bluffs 241
Dearborn 233
Seattle 212
Wilmington 190
Beijing 183
Cambridge 168
Dallas 167
Dublin 149
Princeton 147
Como 131
The Dalles 128
New York 118
Chicago 114
Izmir 111
Nyköping 105
Dong Ket 92
Boardman 89
Rome 87
Los Angeles 81
Ho Chi Minh City 75
Lauterbourg 75
Munich 59
Santa Clara 53
Buffalo 43
San Mateo 41
Hanoi 40
Helsinki 38
Kocaeli 36
Tokyo 32
London 31
Ogden 30
Orem 28
San Diego 27
Turku 25
São Paulo 24
Guangzhou 23
Brooklyn 20
Brussels 19
Mexico City 19
Turin 19
Washington 19
Phoenix 18
Chennai 17
Hefei 17
Warsaw 17
Nanjing 16
Atlanta 15
Toronto 15
Kunming 14
Melbourne 14
Monza 14
Naples 14
Düsseldorf 13
Da Nang 12
Shanghai 12
Accra 11
Amsterdam 11
Boston 11
Frankfurt am Main 11
Shenzhen 11
Stockholm 11
Denver 10
Jinan 10
Magnago 10
San José 10
Verona 10
Gallarate 9
Montreal 9
Norwalk 9
Varese 9
Vienna 9
Ankara 8
Mumbai 8
Nuremberg 8
Ponte Lambro 8
Poplar 8
West Jordan 8
Columbus 7
Haiphong 7
Hangzhou 7
Redmond 7
Shenyang 7
Charlotte 6
Edinburgh 6
Johannesburg 6
Kilburn 6
Manchester 6
Nanchang 6
Newark 6
Totale 9.051
Nome #
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 285
CDKL5 and shootin1 interact and concur in regulating neuronal polarization 280
MeCP2 related studies benefit from the use of CD1 as genetic background 247
Methyl-CpG binding protein 2 (MeCP2) localizes at the centrosome and is required for proper mitotic spindle organization 235
A novel protein, Xenopus p20, influences the stability of MeCP2 through direct interaction 229
Rett syndrome and the urge of novel approaches to study MeCP2 functions and mechanisms of action 228
MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis? 225
CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail 222
CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome 221
CDKL5 localizes at the centrosome and midbody and is required for faithful cell division 221
The neurosteroid pregnenolone reverts microtubule derangement induced by the loss of a functional CDKL5-IQGAP1 complex 217
Characterization of PREP2, a paralog of PREP1, which defines a novel sub-family of the MEINOX TALE homeodomain transcription factors 215
MeCP2 affects skeletal muscle growth and morphology through non cell-autonomous mechanisms 206
What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy. 200
CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery. 198
A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. 198
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation 196
Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells 192
Synaptic synthesis, dephosphorylation and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5. 192
The subcellular localization of PBX1 and EXD proteins depends on nuclear import and export signals and is modulated by association with PREP1 and HTH 189
Retinoic acid receptor a fusion to PML affects its transcriptional and chromatin-remodeling properties 187
Characterization of CDKL5 transcript isoforms in human and mouse 187
PBX1 nuclear export is regulated independently of PBX-MEINOX interaction by PKA phosphorylation of the PBC-B domain 185
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 182
The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis 182
Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms 180
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5 179
CDKL5 ensures excitatory synapse stability by reinforcing NGL1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons 178
Brain phosphorylation of MeCP2 at serene 164 is developmentally regulated and globally alters its chromatin association 173
La cromatina e controllo dell'espressione genica. 170
A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome. 169
Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis 169
Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder 166
Characterization of HIPK2 that, by Associating with MeCP2, Might Function as a Modifier Gene in Rett Syndrome 164
Extrasynaptic N-methyl-D-aspartate (NMDA) receptor stimulation induces cytoplasmic translocation of the CDKL5 kinase and its proteasomal degradation 162
CDKL5 belongs to the same molecular pathway of MeCP2 and is responsible for the early seizure variant of Rett Syndrome 161
Characterization of a novel MeCP2 interacting protein 161
Genetics and mechanisms of disease in Rett Syndrome 161
Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether 160
The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo 157
MECP2 mutations affect ciliogenesis: a novel perspective for Rett syndrome and related disorders 156
DNA methylation and Rett syndrome 155
Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder? 154
Identification and Characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 153
CHARACTERIZATION OF THE CDKL5 GENE INVOLVED IN MENTAL RETARDATION AND INFANTILE SPASMS. 153
Spatio-temporal dynamics and localization of MeCP2 and pathological mutants in living cells 152
2nd European Working Group on Rett Syndrome 150
CDKL5 levels quickly respond to neuronal activity, reinforcing its involvement in synaptic plasticity 149
Identification and characterization of proteins that, interacting with MeCP2, could be involved in Rett Syndrome 147
Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder 144
Characterization of the molecular mechanism underlying GABAA-receptor defects in CDKL5 deficiency disorder 141
Functional Characterization of CDKL5, a Novel Gene Involved in The Onset of Rett Syndrome and Infantile Spasms. 140
Characterization of HIPK2 that, by Associating with MeCP2, Might Function as a Modifier Gene in Rett Syndrome. 138
Pregnenolone-methyl-ether enhances CLIP170 and microtubule functions improving spine maturation and hippocampal deficits related to CDKL5 deficiency 138
Functional Characterization of CDKL5, an X-Linked Gene Involved in Mental Retardation and Epileptic Crisis. 137
DNA methylation in the control of gene silencing during development and human disorders (DisChrom) 135
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 131
Molecular characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 131
Molecular characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 131
Therapeutic potential of pregnenolone and pregnenolone methyl ether on depressive and CDKL5 deficiency disorders: Focus on microtubule targeting 131
CDKL5 interacts with inhibitory postsynaptic scaffolding proteins and regulates synaptic GABAA receptor levels 129
Cromatina e controllo dell'espressione genica 129
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 126
Functional characterization of CDKL5, a novel gene involved in Rett syndrome and infantile spams associated with mental retardation 125
Disruption of the Cellular Regulation of CDKL5 Might be Relevant for Rett Syndrome 124
Functional Characterization of CDKL5, a novel gene involved in the onset of Rett syndrome 122
Functional characterization of CDKL5, a novel gene involved in the onset of Rett Syndrome 122
Revealing a novel and unexpected function of MeCP2, possibly involved in RTT pathophysiology 121
European Working Group on Rett Syndrome 120
Molecular characterization of the CDKL5 gene involved in mental retardation and infantile spams 116
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 115
Identification and characterization of proteins that interacting with MeCP2, could be involved in Rett Syndrome 115
Functional characterization of CDKL5, a novel gene involved in Rett Syndrome and infantile spams 114
Functional characterizationof CDKL5, a novel gene involved in the onset of Rett Syndrome 113
Molecular and functional characterization of CDKL5, a novel X-linked kinase, mainly involved in female mental retardation 111
Functional characterization of CDKL5, a novel kinase involved in Rett syndrome and infantile spasms 109
Molecular genetics of Rett syndrome: when epigenetic signals go unrecognized 107
Novel role of CDKL5 in the inhibitory synapse and a possible therapeutic strategy for CDKL5-related defects 95
The functional role of CDKL5 at the inhibitory synapse and its interaction with the cytoplasmatic collybistin-gephyrin complex 94
Identification and characterization of proteins that interacting with MECP2, could be involved in Rett Syndrome 87
Rett syndrome: from the involved gene(s) to treatment 73
Totale 13.062
Categoria #
all - tutte 52.494
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022440 0 0 0 33 23 21 26 32 36 100 80 89
2022/20231.082 107 82 56 114 70 227 9 149 131 38 50 49
2023/20241.829 282 261 293 289 322 181 20 47 59 29 12 34
2024/20251.318 7 38 238 36 93 72 55 34 161 117 148 319
2025/20263.262 268 203 170 420 305 257 659 201 356 193 147 83
2026/2027792 96 122 352 222 0 0 0 0 0 0 0 0
Totale 13.062